CORE beneficiary partner Syncom and Mercachem, two of the leading European drug discovery Contract Research Organizations (CRO), today announced that the two companies are joining forces effective immediately. The resulting Mercachem-Syncom Group, with more than 300 employees and operations in Nijmegen and Groningen, the Netherlands and Prague, Czech Republic, becomes the premier European mid-sized CRO offering innovative best-in-class chemistry solutions.
Since their inception in 1997 and 1988 respectively, Mercachem and Syncom have established themselves as two of Europe’s leading drug discovery CROs with a focus on high-quality chemistry services to large and mid-size pharmaceutical, life sciences and innovative chemistry customers worldwide. Today’s merger enables the Mercachem-Syncom Group to broaden its offering of integrated drug discovery services and invest into state-of-the-art knowledge base and facilities to address clients’ growing demand for outsourcing solutions. The merger of Mercachem and Syncom and the Group’s growth strategy with a further expansion both organically as well as through partnerships and further acquisitions is supported by Gilde Healthcare, a leading investor in healthcare together with Dutch pension fund service provider PGGM, as co-investor.
See full press release at https://syncom.nl/mercachem-and-syncom-join-forces/
The MSCA CORE network welcomes expressions of interest from post-doctoral researchers who wish to apply for a Marie Skłodowska-Curie Individual Fellowship and will provide support in developing their proposal. (deadline for expressions of interest 30 June 2017, closing date 14 September 2017).
The fellowships will enable successful future Marie SkłodowskaCurie fellows to be hosted by a partner within the network for a period of 12 -24 months to undertake world-class research, career development and knowledge transfer. If successful, the fellowship will provide a generous salary and an allocation for research and training costs.
The CORE network is a Marie Skłodowska-Curie Innovative Training Network (ITN). Partners are international centres of excellence in their field, the academic partners having outstanding records of publications in their research fields, and the industrial partners being at the forefront of product innovation and commercialization in their specific field of activity. We would be interested in supporting Fellowships from across our research portfolio organised within three broad themes:
Partners in the network include – University of Strathclyde (Scotland, UK), Otto-von-Guericke University Magdeburg (Germany), University of Rouen (France), Radboud University Nijmegen (Netherlands), ETH Zurich (Swiss Federal Institute of Technology in Zurich) (Switzerland), University of Manchester (England, UK), Friedrich - Alexander University Erlangen - Nürnberg, (Germany) and Syncom (Netherlands) The partners can facilitate secondments within the network as part of the proposal.
The European Commission eligibility criteria for a Marie SkłodowskaCurie fellowship:
To enhance the chance of success the proposal should cover each of the following points
Please send an outline description of your project idea (300 words) accompanied by your full academic CV and cover letter to email@example.com by the 30 June 2017. Selected proposals will be notified by mid-July 2017 and offered both academic and administrative support from the network and the relevant University Research Office with regards to proposal development. Full proposals must be ready to be submitted by 31 August 2017, the call closing date is 14 September 2017.
If you are interested in discussing this opportunity further, please contact Claire Lynch in the first instance (firstname.lastname@example.org).
ESR Ryusei Oketani's Image Selected as Cover for Scientific Journal
An image in an article by Ryusei Oketani based at the University of Rouen, France has been selected as the cover of Volume 25, Issue 61 of Chemistry: A European Journal..... more
Success Stories: CORE Project, European Commission
The EU-funded CORE project is helping to develop safer, more effective medicines by improving the processes pharmaceutical companies use to separate mirror-image pharmaceutical molecules, which will boost the industry's efficiency and competitiveness..... more